Toggle Nav
Close
  • Menu
  • Setting

Anti-GPC3/Glypican-3 Antibody (Codrituzumab-MMAE)

Catalog No.
F1562
Anti-GPC3/Glypican-3 Antibody (Codrituzumab-MMAE)
Grouped product items
SizePriceStock Qty
100ug
Please inquire
Ship with 3-5 days
1mg
Please inquire
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) is a monoclonal antibody against GPC3 (glypican-3). It induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth, and can be used in the study of hepatocellular carcinoma (HCC). Molecular weight: 145.58 KD.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

150.85 kDa

Shipping

Dry ice

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

Codrituzumab-MMAE

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

P51654

Reactivity

Human

Conjugation

MMAE

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Biological Activity

MMAE is conjugated by sulfhydryl coupling,the DAR value of Anti TROP2 Reference Antibody (Sacituzumab govitecan) antibody is 3.8.

Target

GPC3 / Glypican-3

Note

Please avoid freeze-thaw cycles.